Study to Find Maintenance Dose for Periodic Administration of ASP3550
NCT01261572
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Neoplasms
Interventions
DRUG:
degarelix
Sponsor
Astellas Pharma Inc